HOWL
Werewolf Therapeutics Inc
NASDAQ: HOWL · HEALTHCARE · BIOTECHNOLOGY
$1.07
+1.90% today
Updated 2026-11-03
Market cap
$47.93M
P/E ratio
—
P/S ratio
2.28x
EPS (TTM)
$-0.73
Dividend yield
—
52W range
$0 – $1
Volume
1.0M
Werewolf Therapeutics Inc (HOWL) Financial Forecast & Price Target 2030
Revenue-driven projection model with historical context.
Price target summary
Current price
$1.07
12-Month target
—
2030 Target
—
Intrinsic (DCF)
$4.68
Financial forecast
| Metric | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | $0.0B | $0.0B | $0.0B | $0.0B | $0.0B |
| EPS | — | — | — | — | — |
CAGR applied: — (capped 20%) · P/E: 25.00x (capped 25x) · Margin: -164.80%
Methodology
CAGR-based projection model. Research-backed estimates are being generated — check back soon for analyst consensus and management guidance.